Should pharmaceutical companies dictate business practices for continuing medical education providers?

Are pharmaceutical companies overstepping their boundaries by criticizing continuing medical education providers' business development practices?

The Case

Donald Mahoney, CEO of International CME LLC, an education company in Kansas City, Kansas, believes in rewarding his staff members by paying quarterly bonuses based on the amount of new business generated. Suzie Sunshine, CME director; and several program managers receive these payments and can then do nice things for their families. For Suzie and her colleagues it is a reward for working long hours and spending weekends away from home.

Recently, a group o

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.